Services:
CUSTOM SYNTHESIS
CONTRACT MFG
Contact:

86-574-87319282

86-574-87314919

86-574-27912196

info@nbinno.com

Product details
Bulk supply and Contract manufacturing of Fine Chemicals,Pharmaceutical Intermediates,APIs from kilos to tons
Remdesivir_1809249-37-3

Remdesivir

  • CAS:

    1809249-37-3

  • Synonym:

    Remdesivir
    Remdesivir intermediates
    Remdesivir APIs

Details

Product Name: Remdesivir
Synonym: Remdesivir; GS-5734; GS 5734; GS5734, Prodrug of GS-441524; Prodrug of GS441524; Prodrug of GS441524;
CAS#: 1809249-37-3 
Chemical Formula: C28H36N5O8P 
Exact Mass: 601.2301 
Molecular Weight: 601.5968 
IUPAC/Chemical Name: 2-ethylbutyl ((S)-(((2R,3S,4R,5R)-5-(4-aminopyrrolo[1,2-b]pyridazin-7-yl)-5-cyano-3,4-dihydroxytetrahydrofuran-2-yl)methoxy)(phenoxy)phosphoryl)-L-alaninate
 
Application:
Remdesivir has been found to show reasonable antiviral activity against more distantly related viruses such as respiratory syncytial virus, Junin virus, Lassa fever virus, and MERS-coronavirus and Coronavirus. GS-5734 was rapidly pushed through clinical trials due to the 2013–2016 West African Ebola virus epidemic crisis.
 
Gilead Sciences has recently confirmed that it is demonstrating whether the experimental Ebola drug Remdesivir may cause a fight against a new coronavirus (2019-nCoV) emerging in China. The company said that "active discussions are underway with researchers and clinicians in the United States and China about the potential use of Remdesivir in therapy."
Remdesivir, also known as GS-5734, is an experimental RNA polymerase inhibitor developed by Gilead Sciences in 2014 in collaboration with the Centers for Disease Control and Prevention (CDC) and the U.S. Army Medical Institute for Infectious Diseases Anthony Fossie, director of the National Institute of Allergy and Infectious Diseases at the National Institutes of Health (NIH), stated in a comment on JAMA Network that SARS-CoV and MERS-CoV are being used as prototypes to develop treatment strategies for 2019-nCoV. "Broad-spectrum antivirals, such as Remdesivir, lopinavir / ritonavir and interferon, have shown promise against MERS-CoV in animal models and are evaluating their activity against 2019-nCoV," he said.

Our team is proficient in new route design and route optimization. With the skillful skills to solve problems and the high success rate of the project, we have the ability to provide our customers with the following high quality chemical custom synthesis services.We are specialists in chiral chemistry using both chemocatalysis and biocatalysis technologies, but also have practical operating experience over a wide range of modern synthetic reactions.With an international vision, rich management experience, professional R & D team and integrity and rigorous professionalism, we are committed to providing customers with the highest quality products and services.Dozens of reaction types such as chiral synthesis and resolution, oxidation, reduction, condensation, nitrosation, bromination.The company's production base is equipped with enamel reactors from 50L to 5000L, stainless steel ultra-low temperature reactors and conventional separation and drying equipment.

Are you looking for China or India manufacturers of Remdesivir CAS:1809249-37-3, Remdesivir intermediates factory or Remdesivir APIs supplier? Where can buy Remdesivir APIs or if you want to know the price market of Remdesivir APIs? Welcome to contact us for Remdesivir COA or MSDS.

Laboratory in Ningbo
Our company's R&D company, Ningbo Gino Chemical Co., Ltd. was established in December 2011. we have several fume hoods and kilogram laboratory, and have purchased 20L, 50L reactors and as a preliminary pilot manufacturing of the products. At the same time, We mobilized external resources to establish a pilot facility in Henan Zhumadian and Anhui Anqing, and cooperating with Shandong Zibo and Jiangsu Changzhou factories as a large production facility for our products.

Factory in Shanxi Province
At the end of 2017, We invested workshop in Xinjiang County Longzhou Chemical Co., Ltd., Xinjiang County Coal Mine Park, Yuncheng, Shanxi. The first phase of the reactors were 30* 2000L~5000L, The contract output value is 50 million annually, factory has passed the audit from public listed company domestic and abroad.

Factory in Shandong Province
The production base of liquid rectification chemical products located in Liaocheng, Shandong Province is the main outsourcing production base of our company. The products are sold to leading enterprises and listed companies in the carcass industry for many years. The production, quality and service are stable, delivery is timely, and some individual products are covering 90% of the market.

Factory in Henan Province
In year 2020, We invested workshop in Henan province, the workshop consists of 50*2000L~5000L reactors, The types of reactions that can be manufacturer there are: bromination, cyanidation, and conventional reactions.

Disclaimer: Certain products are for research use only. Not for diagnostic or therapeutic use. Not for human use. INNOPHARMCHEM does not sell to individuals. INNOPHARMCHEM does not warrant that the use or sale of the products delivered under will not infringe the claims of any China or other patents covering the product itself or the use thereof in combination with other products or the operation of any process.

5-Bromo-7-azaindole | Diisobutyl adipate